Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,664 | 87 | 89.6% |
| Education | $193.75 | 2 | 10.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $190.09 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $189.54 | 10 | $0 (2024) |
| Lilly USA, LLC | $167.37 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $159.35 | 11 | $0 (2024) |
| Incyte Corporation | $152.77 | 5 | $0 (2024) |
| ABBVIE INC. | $148.16 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $139.75 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $118.58 | 5 | $0 (2024) |
| BeiGene USA, Inc. | $74.52 | 2 | $0 (2024) |
| Genentech USA, Inc. | $54.56 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,847 | 87 | AstraZeneca Pharmaceuticals LP ($190.09) |
| 2021 | $11.16 | 2 | Genentech USA, Inc. ($11.16) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Oncology | ||||||
| 12/18/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Oncology | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: BioOncology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Oncology | ||||||
| 10/16/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $0.09 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: Hematology/Oncology | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.93 | General |
| 09/16/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Oncology | ||||||
| 09/13/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 345 | 354 | $58,515 | $15,335 |
| 2022 | 7 | 404 | 424 | $63,647 | $16,842 |
| 2021 | 3 | 97 | 97 | $18,044 | $5,745 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 153 | 160 | $27,360 | $7,122 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 92 | $23,184 | $6,774 | 29.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 20 | 20 | $3,080 | $692.40 | 22.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 27 | 27 | $1,809 | $437.40 | 24.2% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 27 | 27 | $2,214 | $213.57 | 9.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 28 | 28 | $868.00 | $95.48 | 11.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 253 | 271 | $46,341 | $12,966 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 43 | $10,836 | $2,947 | 27.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 24 | 24 | $1,608 | $383.41 | 23.8% |
| 87088 | Bacterial urine culture | Office | 2022 | 29 | 29 | $2,262 | $228.09 | 10.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 33 | 33 | $1,023 | $113.26 | 11.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 13 | $741.00 | $110.07 | 14.9% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2022 | 11 | 11 | $836.00 | $93.94 | 11.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 37 | $9,324 | $2,968 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 49 | $8,379 | $2,739 | 32.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 11 | $341.00 | $38.28 | 11.2% |
About Sarah Mackey, FNP-C
Sarah Mackey, FNP-C is a Nurse Practitioner healthcare provider based in Decatur, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2021. The National Provider Identifier (NPI) number assigned to this provider is 1275102113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Mackey, FNP-C has received a total of $1,858 in payments from pharmaceutical and medical device companies, with $1,847 received in 2024. These payments were reported across 89 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,664).
As a Medicare-enrolled provider, Mackey has provided services to 846 Medicare beneficiaries, totaling 875 services with total Medicare billing of $37,923. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Decatur, IL
- Active Since 06/24/2021
- Last Updated 01/31/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1275102113
Products in Payments
- KEYTRUDA (Biological) $189.54
- EPKINLY (Drug) $136.06
- LIBTAYO (Biological) $118.58
- CALQUENCE (Drug) $82.20
- IMFINZI (Biological) $72.93
- VERZENIO (Drug) $61.61
- CARVYKTI (Drug) $54.70
- Epkinly (Drug) $50.41
- SCEMBLIX (Drug) $47.30
- BRUKINSA (Drug) $47.03
- LUTATHERA (Drug) $46.24
- Columvi (Biological) $43.40
- AYVAKIT (Drug) $41.81
- KISQALI (Drug) $41.17
- DARZALEX (Biological) $39.84
- Lenvima (Drug) $34.92
- JAKAFI (Drug) $33.75
- Enhertu (Drug) $27.84
- TEVIMBRA (Drug) $27.49
- FRUZAQLA (Drug) $25.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Decatur
Ms. Maria Hanik, Msn, MSN
Nurse Practitioner — Payments: $36,692
Karen Bauer, Crnp, CRNP
Nurse Practitioner — Payments: $13,821
Kristi Toennies, Np, NP
Nurse Practitioner — Payments: $6,846
Amy Wynn, Crnp, CRNP
Nurse Practitioner — Payments: $6,594
Mrs. Amanda Adcock, Crnp, CRNP
Nurse Practitioner — Payments: $6,131
Ann Wood, Msn, Crnp, MSN, CRNP
Nurse Practitioner — Payments: $5,384